Mimedx (MDXG) Share-based Compensation (2010 - 2026)

Mimedx has disclosed Share-based Compensation across 17 years of filings, most recently posting -$1.3 million for Q2 2026.

• In Q2 2026, Share-based Compensation fell 126.73% year-over-year to -$1.3 million; the TTM figure through Jun 2026 stood at $4.1 million (down 76.59% YoY), while the FY2025 annual figure was $16.4 million, down 3.17% from the prior year.
• Share-based Compensation came in at -$1.3 million for Q2 2026 at Mimedx, up from -$2.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.9 million in Q3 2025 to a low of -$2.0 million in Q1 2026.
• Average Share-based Compensation over 5 years is $3.2 million, with a median of $4.1 million recorded in 2023.
• Year-over-year, Share-based Compensation jumped 727.55% in 2023 and slumped 147.21% in 2026.
• Over 5 years, Share-based Compensation stood at $530000.0 in 2022, then jumped by 727.55% to $4.4 million in 2023, then increased by 7.0% to $4.7 million in 2024, then slumped by 47.52% to $2.5 million in 2025, then plunged by 151.56% to -$1.3 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were -$1.3 million in Q2 2026, -$2.0 million in Q1 2026, and $2.5 million in Q4 2025.